| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8073ad673dea135a5a788f8bc35ad9f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 |
| filingDate |
2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aff1b058a99822aa1274ecdbf6faadc |
| publicationDate |
2002-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002241286-A |
| titleOfInvention |
Immunoactivator having interleukin-12 production-inducing activity |
| abstract |
(57) [Summary] (Modified) [Problem] To provide an immunostimulating agent having few side effects and a high effect. SOLUTION: p-Aminobenzoic acid-N is used as an active ingredient. -An immune activator comprising D-xylosid sodium salt. The compound is interleukin- Since it shows 12 production inducing activity, atopic dermatitis, It is expected to be effective as a therapeutic agent for allergy and autoimmune diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010249564-A |
| priorityDate |
2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |